Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.82 |
52 Week High | €1.23 |
52 Week Low | €0.71 |
Beta | 0 |
11 Month Change | 4.43% |
3 Month Change | -8.33% |
1 Year Change | -13.88% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -8.33% |
Recent News & Updates
Recent updates
Shareholder Returns
MED | GR Luxury | GR Market | |
---|---|---|---|
7D | 5.8% | 0.9% | 0.03% |
1Y | -13.9% | -5.0% | 9.5% |
Return vs Industry: MED underperformed the Greek Luxury industry which returned -5% over the past year.
Return vs Market: MED underperformed the Greek Market which returned 9.5% over the past year.
Price Volatility
MED volatility | |
---|---|
MED Average Weekly Movement | 7.3% |
Luxury Industry Average Movement | 4.4% |
Market Average Movement | 4.0% |
10% most volatile stocks in GR Market | 5.8% |
10% least volatile stocks in GR Market | 2.5% |
Stable Share Price: MED's share price has been volatile over the past 3 months compared to the Greek market.
Volatility Over Time: MED's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Greek stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | n/a | med.com.gr |
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. engages in the manufacture, wholesale, and retail trade of swimwear, underwear, bathing accessories, men's and women's clothing, children's clothing, footwear, bags, towels, sunglasses, and other related products in Greece and internationally. The company was founded in 1999 and is based in Thessaloniki, Greece.
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. Fundamentals Summary
MED fundamental statistics | |
---|---|
Market cap | €9.83m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MED income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MED perform over the long term?
See historical performance and comparison